Ripollés Javier, Espinosa Angel, Martínez-Hurtado Eugenio, Abad-Gurumeta Alfredo, Casans-Francés Rubén, Fernández-Pérez Cristina, López-Timoneda Francisco, Calvo-Vecino José María
Departamento de Anestesia, Hospital Universitario Infanta Leonor, Universidad Complutense de Madrid, Madrid, Espanha.
Department of Anesthesia, Blekinge County Council Hospital, WämöCenter, Karlskrona, Suécia.
Rev Bras Anestesiol. 2016 Sep-Oct;66(5):513-28. doi: 10.1016/j.bjan.2015.02.002. Epub 2016 Jul 18.
The goal directed hemodynamic therapy is an approach focused on the use of cardiac output and related parameters as end-points for fluids and drugs to optimize tissue perfusion and oxygen delivery. Primary aim: To determine the effects of intraoperative goal directed hemodynamic therapy on postoperative complications rates.
A meta-analysis was carried out of the effects of goal directed hemodynamic therapy in adult noncardiac surgery on postoperative complications and mortality using Preferred Reporting Items for Systematic Reviews and Meta-Analyses methodology. A systematic search was performed in Medline PubMed, Embase, and the Cochrane Library (last update, October 2014). Inclusion criteria were randomized clinical trials in which intraoperative goal directed hemodynamic therapy was compared to conventional fluid management in noncardiac surgery. Exclusion criteria were trauma and pediatric surgery studies and that using pulmonary artery catheter. End-points were postoperative complications (primary) and mortality (secondary). Those studies that fulfilled the entry criteria were examined in full and subjected to quantifiable analysis, predefined subgroup analysis (stratified by type of monitor, therapy, and hemodynamic goal), and predefined sensitivity analysis.
51 RCTs were initially identified, 24 fulfilling the inclusion criteria. 5 randomized clinical trials were added by manual search, resulting in 29 randomized clinical trials in the final analysis, including 2654 patients. A significant reduction in complications for goal directed hemodynamic therapy was observed (RR: 0.70, 95% CI: 0.62-0.79, p<0.001). No significant decrease in mortality was achieved (RR: 0.76, 95% CI: 0.45-1.28, p=0.30). Quality sensitive analyses confirmed the main overall results.
Intraoperative goal directed hemodynamic therapy with minimally invasive monitoring decreases postoperative complications in noncardiac surgery, although it was not able to show a significant decrease in mortality rate.
目标导向血流动力学治疗是一种以心输出量及相关参数作为液体和药物治疗终点,以优化组织灌注和氧输送的治疗方法。主要目的:确定术中目标导向血流动力学治疗对术后并发症发生率的影响。
采用系统评价和Meta分析的首选报告项目方法,对目标导向血流动力学治疗在成人非心脏手术中对术后并发症和死亡率的影响进行Meta分析。在Medline PubMed、Embase和Cochrane图书馆(最后更新时间为2014年10月)进行系统检索。纳入标准为随机临床试验,其中在非心脏手术中将术中目标导向血流动力学治疗与传统液体管理进行比较。排除标准为创伤和儿科手术研究以及使用肺动脉导管的研究。终点指标为术后并发症(主要)和死亡率(次要)。对符合纳入标准的研究进行全面审查,并进行可量化分析、预定义亚组分析(按监测类型、治疗方法和血流动力学目标分层)和预定义敏感性分析。
最初识别出51项随机对照试验,24项符合纳入标准。通过手工检索又增加了5项随机临床试验,最终分析纳入29项随机临床试验,包括2654例患者。观察到目标导向血流动力学治疗可显著降低并发症发生率(RR:0.70,95%CI:0.62-0.79,p<0.001)。死亡率未显著降低(RR:0.76,95%CI:0.45-1.28,p=0.30)。质量敏感性分析证实了主要总体结果。
术中采用微创监测的目标导向血流动力学治疗可降低非心脏手术的术后并发症,尽管未能显著降低死亡率。